← Back to catalogue

Bd Max™ Gbs

FDA UDI

Class I (US FDA UDI)

by Becton Dickinson And Company

Identity

Trade Name
BD MAX™ GBS FDA UDI
Generic Name
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
BD MAX™ GBS FDA UDI
Model / Reference
441772 FDA UDI
Description
BD MAX™ GBS FDA UDI

Identifiers

Catalog Number
441772 FDA UDI
Primary DI / UDI-DI
00382904417727 FDA UDI
510(k) Number
K111860 FDA UDI
FDA Product Code
NJR FDA UDI
OOI FDA UDI
GMDN Term
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
866.3740 FDA UDI
862.2570 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)

Bd Max™ Gbs by Becton Dickinson And Company — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 46a3eea7-fcae-445e-911b-378fef9123ed 37 fields · synced May 31, 2026